留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

非酒精性脂肪性肝病与急性胰腺炎的关系

王婷婷 何家俊 杨楚婷 李圆浩 陈炜炜 刘军

王婷婷, 何家俊, 杨楚婷, 等. 非酒精性脂肪性肝病与急性胰腺炎的关系[J]. 临床肝胆病杂志, 2021, 37(3): 729-732. DOI: 10.3969/j.issn.1001-5256.2021.03.047
引用本文: 王婷婷, 何家俊, 杨楚婷, 等. 非酒精性脂肪性肝病与急性胰腺炎的关系[J]. 临床肝胆病杂志, 2021, 37(3): 729-732. DOI: 10.3969/j.issn.1001-5256.2021.03.047
WANG TT, HE JJ, YANG CT, et al. Association between nonalcoholic fatty liver disease and acute pancreatitis [J]. J Clin Hepatol, 2021, 37(3): 729-732. DOI: 10.3969/j.issn.1001-5256.2021.03.047
Citation: WANG TT, HE JJ, YANG CT, et al. Association between nonalcoholic fatty liver disease and acute pancreatitis [J]. J Clin Hepatol, 2021, 37(3): 729-732. DOI: 10.3969/j.issn.1001-5256.2021.03.047

非酒精性脂肪性肝病与急性胰腺炎的关系

DOI: 10.3969/j.issn.1001-5256.2021.03.047
基金项目: 

中国博士后科学基金面上资助 2018M632260

江苏省基础研究计划(自然科学基金)青年基金 BK20190907

江苏省第十六批“六大人才高峰”高层次人才项目 WSN-325

详细信息
    作者简介:

    王婷婷(1996—),女,主要从事肝胆胰疾病研究

    通讯作者:

    刘军,sbyy_liujun@163.com

  • 利益冲突声明:所有作者均声明不存在利益冲突。
  • 作者贡献声明: 王婷婷负责论文撰写与修改;何家俊、杨楚婷、李圆浩协助论文修改;陈炜炜负责论文选题和指导;刘军提出研究思路和方法。
  • 中图分类号: R575.5;R576

Association between nonalcoholic fatty liver disease and acute pancreatitis

  • 摘要: 急性胰腺炎是临床常见的急腹症之一。非酒精性脂肪性肝病作为代谢综合征的肝脏表现,与急性胰腺炎的严重程度及预后密切相关。阐述了非酒精性脂肪性肝病在急性胰腺炎发生发展过程中的作用机制,指出非酒精性脂肪性肝病可通过多种途径诱发急性胰腺炎并加重其病情严重程度。
  • [1] LI XY, HE C, ZHU Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol, 2020, 26(18): 2187-2193. DOI: 10.3748/wjg.v26.i18.2187
    [2] BUREK J, JAWORSKA K, WITKOWSKI G, et al. A case of acute pancreatitis - does step-up protocol always indicated?[J]. Pol Merkur Lekarski, 2020, 48(284): 100-102.
    [3] LIU J, ZHANG B. The lived experience of inpatients with acute recurrent pancreatitis: A qualitative research study from west China[J]. Gastroenterol Nurs, 2020, 43(3): 249-257. DOI: 10.1097/SGA.0000000000000442
    [4] WANG J, HE W, TSAI PJ, et al. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease[J]. Lipids Health Dis, 2020, 19(1): 72. DOI: 10.1186/s12944-020-01210-0
    [5] MITRA S, DE A, CHOWDHURY A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases[J]. Transl Gastroenterol Hepatol, 2020, 5: 16. DOI: 10.21037/tgh.2019.09.08
    [6] WONG SW, CHAN WK. Epidemiology of non-alcoholic fatty liver disease in Asia[J]. Indian J Gastroenterol, 2020, 39(1): 1-8. DOI: 10.1007/s12664-020-01018-x
    [7] MIKOLASEVIC I, ORLIC L, POROPAT G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis[J]. Eur J Intern Med, 2017, 38: 73-78. DOI: 10.1016/j.ejim.2016.10.019
    [8] WU D, ZHANG M, XU S, et al. Nonalcoholic fatty liver disease aggravated the severity of acute pancreatitis in patients[J]. Biomed Res Int, 2019, 2019: 9583790. http://www.researchgate.net/publication/330561517_Nonalcoholic_Fatty_Liver_Disease_Aggravated_the_Severity_of_Acute_Pancreatitis_in_Patients
    [9] WORM N. Beyond body weight-loss: Dietary strategies targeting intrahepatic fat in NAFLD[J]. Nutrients, 2020, 12(5): e1316. DOI: 10.3390/nu12051316
    [10] SWEET PH, KHOO T, NGUYEN S. Nonalcoholic fatty liver disease[J]. Prim Care, 2017, 44(4): 599-607. DOI: 10.1016/j.pop.2017.07.003
    [11] MIKOLASEVIC I, MILIC S, ORLIC L, et al. Metabolic syndrome and acute pancreatitis[J]. Eur J Intern Med, 2016, 32: 79-83. DOI: 10.1016/j.ejim.2016.04.004
    [12] KAO WY, CHANG IW, CHEN CL, et al. Fibroscan-based score to predict significant liver fibrosis in morbidly obese patients with nonalcoholic fatty liver disease[J]. Obes Surg, 2020, 30(4): 1249-1257. DOI: 10.1007/s11695-019-04192-w
    [13] JIN D, NIU CY. The effect of nonalcoholic fatty liver disease on the severity of acute pancreatitis[J]. J Prac Med, 2017, 33(21): 3563-3565.

    金豆, 牛春燕. 非酒精性脂肪性肝病对急性胰腺炎严重程度的影响[J]. 实用医学杂志, 2017, 33(21): 3563-3565.
    [14] SZENTESI A, PARNICZKY A, VINCZE Á, et al. Multiple hits in acute pancreatitis: Components of metabolic syndrome synergize each other's deteriorating effects[J]. Front Physiol, 2019, 10: 1202. DOI: 10.3389/fphys.2019.01202
    [15] STEFANUTTI C, DI GIACOMO S, LABBADIA G. Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis[J]. Transfus Apher Sci, 2011, 45(1): 3-7. DOI: 10.1016/j.transci.2011.06.013
    [16] LI HL. Study on the relationship between obesity, diabetes, hyperlipidemia and acute pancreatitis[D]. Jinan: University of Shandong, 2016.

    李慧丽. 肥胖、糖尿病、高脂血症与急性胰腺炎关系研究[D]. 济南: 山东大学, 2016.
    [17] KARPAVICIUS A, DAMBRAUSKAS Z, SILEIKIS A, et al. Value of adipokines in predicting the severity of acute pancreatitis: Comprehensive review[J]. World J Gastroenterol, 2012, 18(45): 6620-6627. DOI: 10.3748/wjg.v18.i45.6620
    [18] ZHONG R, YAN YF, JIANG X, et al. Clinical features of acute pancreatitis with metabolic syndrome and influencing factors for prognosis[J]. J Clin Hepatol, 2020, 36(8): 1794-1798. DOI: 10.3969/j.issn.1001-5256.2020.08.023

    钟瑞, 严永峰, 蒋鑫, 等. 急性胰腺炎合并代谢综合征的临床特征及预后影响因素分析[J]. 临床肝胆病杂志, 2020, 36(8): 1794-1798. DOI: 10.3969/j.issn.1001-5256.2020.08.023
    [19] YOUNOSSI ZM, GOLABI P, de AVILA L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis[J]. Hepatol, 2019, 71(4): 793-801. DOI: 10.1016/j.jhep.2019.06.021
    [20] FUJⅡ H, KAWADA N, Japan Study Group of NAFLD. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease[J]. Int J Mol Sci, 2020, 21(11): 3863. DOI: 10.3390/ijms21113863
    [21] WANG YH, GAO Y. Research progress in diagnosis and treatment of non-alcoholic fatty liver disease combinated with type 2 diabetes mellitus[J]. J Jilin Univ (Med Edit), 2020, 46(6): 1324-1331.

    王雨涵, 高影. 非酒精性脂肪性肝病并发2型糖尿病诊断和治疗的研究进展[J]. 吉林大学学报(医学版), 2020, 46(6): 1324-1331.
    [22] YUAN S, LIAO J, CAI R, et al. Acute pancreatitis concomitant with diabetic ketoacidosis: A cohort from South China[J]. J Int Med Res, 2020, 48(3): 300060520912128. http://www.researchgate.net/publication/340292451_Acute_pancreatitis_concomitant_with_diabetic_ketoacidosis_a_cohort_from_South_China/download
    [23] de PRETIS N, AMODIO A, FRULLONI L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management[J]. United European Gastroenterol J, 2018, 6(5): 649-655. DOI: 10.1177/2050640618755002
    [24] HOU S, TANG X, CUI H, et al. Fatty liver disease is associated with the severity of acute pancreatitis: A systematic review and meta-analysis[J]. Int J Surg, 2019, 65: 147-153. DOI: 10.1016/j.ijsu.2019.04.003
    [25] BHATIA M. Inflammatory response on the pancreatic acinar cell injury[J]. Scand J Surg, 2005, 94(2): 97-102. DOI: 10.1177/145749690509400203
    [26] ZHANG YH, DING SY. Analysis on relationship between non-alcoholic fatty liver disease and gallstone disease[J]. J Zhengzhou Univ(Med Sci), 2019, 54(5): 716-719.

    张宇恒, 丁素英. 非酒精性脂肪肝与胆囊结石的关系分析[J]. 郑州大学学报(医学版), 2019, 54(5): 716-719.
    [27] HUANG Y, CHEN H. Research progress in association between nonalcoholic fatty liver disease and gallstone disease[J]. J Clin Hepatol, 2014, 30(11): 1217-1220. DOI: 10.3969/j.issn.1001-5256.2014.11.033

    黄英, 陈洪. 非酒精性脂肪性肝病与胆石症的相关性研究进展[J]. 临床肝胆病杂志, 2014, 30(11): 1217-1220. DOI: 10.3969/j.issn.1001-5256.2014.11.033
    [28] CHEN YF. An analysis of the prevalence and its risk factors of gallbladder diseases in patients with fatty liver disease[D]. Jinan: University of Jinan, 2014.

    陈永芳. 脂肪肝合并胆囊疾病的患病率及对其危险因素的相关性分析[D]. 济南: 济南大学, 2014.
    [29] FENG L, ZHANG Y, XU DQ, et al. Progress in diagnosis and treatment of acute biliary pancreatitis[J]. Chin J Bases Clin General Surg, 2019, 26(4): 508-512.

    冯磊, 张轶, 徐德全, 等. 急性胆源性胰腺炎诊治进展[J]. 中国普外基础与临床杂志, 2019, 26(4): 508-512.
    [30] BAFFY G. Kupffer cells in non-alcoholic fatty liver disease: The emerging view[J]. J Hepatol, 2009, 51(1): 212-223. DOI: 10.1016/j.jhep.2009.03.008
    [31] XU FZ, XIONG LY, WAN JY, et al. The role of Kupffer cells in nonalcoholic fatty liver disease[J]. Chem Life, 2019, 39(3): 464-471.

    徐芳芷, 熊令伊, 万敬员, 等. Kupffer细胞在非酒精性脂肪肝病中的作用[J]. 生命的化学, 2019, 39(3): 464-471.
    [32] XU C, QIAO Z, LU Y, et al. Influence of fatty liver on the severity and clinical outcome in acute pancreatitis[J]. PLoS One, 2015, 10(11): e0142278. DOI: 10.1371/journal.pone.0142278
    [33] WANG Q, DU J, YU P, et al. Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis[J]. Sci Rep, 2015, 5: 17833. DOI: 10.1038/srep17833
    [34] WANG Q. Role of AAT decompensation in acute pancreatitis and its related molecular mechanism in hepatic steatosis[D]. Xi'an: The Fourth Military Medical University, 2016.

    王谦. AAT失代偿在脂肪肝大鼠急性胰腺炎中的作用和机制研究[D]. 西安: 第四军医大学, 2016.
    [35] LI X, GUO X, JI H, et al. Relationships between metabolic comorbidities and occurrence, severity, and outcomes in patients with acute pancreatitis: A narrative review[J]. Biomed Res Int, 2019, 2019: 2645926. http://www.ncbi.nlm.nih.gov/pubmed/31687382
    [36] WANG Q, YAN H, WANG G, et al. RNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: A gene expression profiling comparative study[J]. Sci Rep, 2017, 7(1): 734. DOI: 10.1038/s41598-017-00821-5
    [37] CUI H, ZHANG X. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: A literature review[J]. J Pediatr Endocrinol Metab, 2020, 33(5): 579-584. DOI: 10.1515/jpem-2019-0595
    [38] DUAN WL, ZHAO SZ, ZHAO L. Progress in the pathogenesis and treatment of non-alcoholic fatty liver disease[J]. J Log Univ CAPF(Med Sci), 2019, 28(8): 79-84.

    段文丽, 赵淑珍, 赵莉. 非酒精性脂肪性肝病的发病机制及其治疗研究进展[J]. 武警后勤学院学报(医学版), 2019, 28(8): 79-84.
  • 加载中
计量
  • 文章访问数:  44
  • HTML全文浏览量:  9
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-09-12
  • 修回日期:  2020-10-13
  • 刊出日期:  2021-03-16
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回